Educated Patient® Multiple Myeloma Summit

Driving Treatment Decisions and Predicting Long-Term Outcomes in Multiple Myeloma

October 22nd 2021

Treating multiple myeloma to minimize the amount of residual disease in the body is an ultimate goal, which can be achieved through initial therapy and maintenance therapy.

It Takes Teamwork to Treat Myeloma, and Patients Are Key Players

October 5th 2021

Patients with myeloma should not be afraid to seek out second opinions or speak up about side effects that they are experiencing.

Educated Patient® Multiple Myeloma Summit in Partnership with Sylvester Comprehensive Cancer Center, University of Miami

October 2nd 2021

View the full CURE® Educated Patient® Multiple Myeloma Summit in Partnership with Sylvester Comprehensive Cancer Center, University of Miami on demand.

How a Plasma Cell Disorder Called MGUS Can Progress to Multiple Myeloma

May 13th 2021

All patients with multiple myeloma have had MGUS, so what is it?

How Treating Myeloma is About Extending Remissions and Making it ‘Livable’

April 12th 2021

In an interview, Dr. Nina Shah of UCSF Helen Diller Family Comprehensive Cancer Center discusses how she changed her perspective on finding a cure for myeloma and what her goals are when it comes to treating her patients.

Taking a Look Back at CURE®’s Educated Patient® Multiple Myeloma Summit

April 11th 2021

CURE® is looking back at the Educated Patient® Multiple Myeloma Summit, a half-day virtual event to educate, inform and connect patients with multiple myeloma to a variety of experts in the field.

Myeloma Therapies Create an ‘Optimistic Picture’ for Patients’ Futures

April 6th 2021

In an interview, Dr. Andrew Yee of Massachusetts General Hospital discusses how a multiple myeloma diagnosis affects a patient’s life and how hopeful he is about helping them lead normal lives.

What It’s Like to Be a Myeloma Millennial, Or, ‘Myelennial’

April 5th 2021

In an interview, Dr. Nina Shah of UCSF Helen Diller Family Comprehensive Cancer Center explains what a myeloma millennial, or ‘myelennial,’ is, and how recent advances in multiple myeloma treatments inspired the term.

Treatments for Multiple Myeloma Are Transforming Lives

April 1st 2021

The biggest fear for many patients, according to an expert from The University of Texas MD Anderson Cancer Center, is when they hear that myeloma, for most patients, is not curable. However, she notes that every few years patient survival is increasing.

‘Knowledge Is Power’ When Learning About Treatments for Late Relapsed/Refractory Multiple Myeloma

March 31st 2021

An expert discusses therapies that are changing the treatment landscape and the research to make this disease more livable.

Spotlighting New and Emerging Therapies in Myeloma

March 24th 2021

There is a lot of hype on T-cell engagers and CAR T-cell therapy, but there are other new and exciting immunotherapies in myeloma not talked about that may be approved in the near future, according to an expert.

Multiple Myeloma 101: An Incurable But ‘Very Treatable’ Disease

March 22nd 2021

Although a multiple myeloma diagnosis can be overwhelming for patients, an expert from the Massachusetts General Hospital Cancer Center notes how the disease is very treatable, and that patients can go on to lead full lives.

Assessing Unique Patient Characteristics Critical in Deciding Therapy Options for Early Relapse Myeloma

March 18th 2021

An expert discusses the treatment options that patients with early relapse myeloma have to treat their recurrent disease, which often follows a cyclical pattern.

Educated Patient® Multiple Myeloma Summit: March 13, 2021

March 13th 2021

View the full CURE Educated Patient Multiple Myeloma Summit on demand.

Clinical Trials on Smoldering Myeloma May Open Doors to More Precision Medicine

December 29th 2020

In an interview with CURE®, Dr. Irene M. Ghobrial discussed smoldering myeloma, a precursor condition that may progress to multiple myeloma, how to proceed if diagnosed with the condition and the available opportunities to participate in clinical trials to learn more.

Accurate Diagnosis, Staging Improves Myeloma Outcomes

December 16th 2020

Advancements in the diagnosis and staging of multiple myeloma continue to shape treatment decisions and improve outcomes.

A Beginner’s Guide to Understanding Myeloma

December 16th 2020

In an interview with CURE®, Dr. Giada Bianchi provides patients an overview of myeloma, including symptoms and risk factors of the disease people should look out for.

Understanding New Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

December 15th 2020

The complexity of multiple myeloma can make it difficult to treat, but with complexity comes more avenues for researchers to explore what treatments work best. Recently, CURE® spoke with an expert from Dana-Farber Cancer Institute on what patients can expect to see from the clinical setting.

Educated Patient Multiple Myeloma Summit On-Demand: Nov. 21, 2020

December 8th 2020

View the full CURE®Educated Patient® Multiple Myeloma Summit here!

Evolving Standards and Heated Debates in the Treatment of Newly Diagnosed Multiple Myeloma

December 4th 2020

Evolving standards of care in newly diagnosed multiple myeloma (MM) have given patients a wider variety of possibilities but can also be disconcerting. In a presentation during CURE®’s Educated Patient® Multiple Myeloma Summit, Dr. Clifton Mo, of Dana-Farber Cancer Institute, explores the treatment landscape and breaks down what these different options can offer patients.

Understanding the Key Aspects of a Multiple Myeloma Diagnosis

January 3rd 2020

A multiple myeloma expert helps newly diagnosed patients understand the standard of care for their disease.

Precision Medicine Paves the Way for Exciting Treatment Combinations for Patients with Multiple Myeloma

December 25th 2019

Patients with multiple myeloma have a lot to look forward to in the treatment space thanks to precision medicine, but one treatment option alone will not cure the disease.

Coming to Grips with A Multiple Myeloma Diagnosis

December 21st 2019

At the 2019 CURE® Educated Patient® Summit on Multiple Myeloma patient advocate and 10-year survivor Terry White had the chance to share advice on handling a cancer diagnosis.

Addressing Questions From Newly Diagnosed Patients with Multiple Myeloma

December 20th 2019

Naturally, newly diagnosed patients with multiple myeloma have a lot of questions for their physicians. Dr. Joshua Richter had the time to discuss some of them.

Understanding the Role of Immunoglobulins in Multiple Myeloma

December 16th 2019

At CURE’s Educated Patient Summit on Multiple Myeloma Dr. Shebli Atrash had the chance to further discuss with CURE what questions he addresses most when patients with multiple myeloma undergo diagnostic testing.

MRD Measurement Shows Promise for Making Informed Treatment Decisions in Myeloma

December 15th 2019

At CURE’s Educated Patient Summit on Multiple Myeloma, Dr. Barry Paul discussed the role of minimal residual disease measurement and how it may be used in the future to determine treatment options for patients with myeloma.

Patients with Multiple Myeloma Give Themselves Hope Through Treatment

December 15th 2019

Dr. Cesar Rodriguez offers a message of hope and self-determination for patients with multiple myeloma.